Prebiotics and the Management of Hyperuricemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Hyperuricemia is a major risk factor for many chronic diesease. Recently, gut mcirobiota has been identified as a novel theraputic target for hyperuricemia. Both annimal studies and pilot human trials have demonstrated that administration of prebiotics help delay the progression of hyperuricemia throuh several mechanisms. This trial aims to examine its protective effects and potential mechanisms in clinical trials.
Epistemonikos ID: ea37417ea9cd5f53ac641b8a2cbca6caf9ef4952
First added on: May 22, 2024